Cargando…
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
OBJECTIVE: To describe the experience managing treatment-refractory immune-mediated necrotizing myopathies (IMNM) with high-dose cyclophosphamide (HiCy) therapy. METHODS: Five patients with severe refractory IMNM who were treated with HiCy without stem cell rescue were identified. Their medical reco...
Autores principales: | Mecoli, Christopher A., Lahouti, Arash H., Brodsky, Robert A., Mammen, Andrew L., Christopher-Stine, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619913/ https://www.ncbi.nlm.nih.gov/pubmed/28975138 http://dx.doi.org/10.1212/NXI.0000000000000381 |
Ejemplares similares
-
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
Publicado: (2018) -
Pediatric immune-mediated necrotizing myopathy
por: Wang, Chen-Hua, et al.
Publicado: (2023) -
High Dose Cyclophosphamide Treatment for Autoimmune Disorders
por: Brodsky, Robert A.
Publicado: (2002) -
Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy
por: Stroie, Oana P, et al.
Publicado: (2020) -
Necrotizing autoimmune myopathy
por: Babu, Sachin Suresh, et al.
Publicado: (2016)